Aigen Investment Management, LP Catalent, Inc. Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $231,309 - $334,745	7,188 Added 129.56%	12,736 $572,000
Q3 2023 Nov 13, 2023	SELL	$44.2 - $50.2 $77,394 - $87,900	-1,751 Reduced 23.99%	5,548 $252,000
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $232,546 - $490,930	7,299 New	7,299 $316,000
Q4 2021 Feb 11, 2022	SELL	$119.57 - $139.07 $1.03 Million - $1.2 Million	-8,594 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $938,206 - $1.22 Million	8,594 New	8,594 $1.14 Million
Q2 2021 Aug 10, 2021	SELL	$100.34 - $115.69 $597,725 - $689,165	-5,957 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $604,695 - $746,233	5,957 New	5,957 $627,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.